Medicare Enrolled

Dr. Amy Lazar, M.D.

Otolaryngology · Bridgewater, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
245 US HIGHWAY 22 FL 3, Bridgewater, NJ 08807
9087221022
In practice since 2006 (20 years)
NPI: 1568441988 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lazar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lazar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lazar

Dr. Amy Lazar is an otolaryngology specialist in Bridgewater, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lazar performed 2,044 Medicare services across 1,588 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lazar received a total of $2,543 from 31 pharmaceutical and/or device companies across 146 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in otolaryngology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lazar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 22% volume in NJ $2,543 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,044
Medicare services
Top 22% in NJ for otolaryngology
1,588
Unique beneficiaries
$95
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~102 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
571 $110 $225
Nasal endoscopy
A diagnostic procedure that uses a thin, lighted tube to examine the inside of the nasal passages.
396 $161 $766
Ear wax removal
A procedure to remove impacted ear wax from the ear canal.
326 $32 $290
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
214 $139 $360
Impacted earwax removal by physician
Removal of impacted earwax from one or both ears by a physician on the same day as audiologic testing.
202 $40 $109
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
142 $75 $217
Middle ear function test
A diagnostic test used to evaluate how well the middle ear is functioning.
93 $15 $63
Flexible laryngoscopy
A diagnostic exam of the voice box using a flexible endoscope to visualize the larynx.
42 $116 $290
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
22 $47 $130
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
18 $13 $70
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
18 $9 $95
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,543
Total received (2018-2024)
Avg $363/year across 7 years
Top 25% in NJ for otolaryngology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
146
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,490 (97.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$53 (2.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$585
2023
$550
2022
$247
2021
$59
2020
$136
2019
$588
2018
$378

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AERIN MEDICAL INC.
$195
GENZYME CORPORATION
$164
Optinose US, Inc.
$83
Takeda Pharmaceuticals U.S.A., Inc.
$32
Medtronic, Inc.
$30
Incyte Corporation
$29
Lilly USA, LLC
$21
Regeneron Healthcare Solutions, Inc.
$16
GlaxoSmithKline, LLC.
$14
Top 3 companies account for 75.6% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$538
Regeneron Healthcare Solutions, Inc.
$287
Optinose US, Inc.
$199
GlaxoSmithKline, LLC.
$199
AERIN MEDICAL INC.
$195
Stryker Corporation
$146
Aerin Medical Inc.
$97
ARBOR PHARMACEUTICALS, INC.
$96
Novartis Pharmaceuticals Corporation
$87
OptiNose US, Inc.
$81
Takeda Pharmaceuticals U.S.A., Inc.
$75
Mylan Specialty L.P.
$58
SANOFI-AVENTIS U.S. LLC
$53
Medtronic, Inc.
$47
CSL Behring
$45
ALK-Abello, Inc
$42
Shire North American Group Inc
$40
Kaleo, Inc.
$35
DAVOL INC.
$32
Incyte Corporation
$29
Lilly USA, LLC
$21
Smith+Nephew, Inc.
$21
Acclarent, Inc
$18
Genentech USA, Inc.
$16
Hikma Pharmaceuticals USA
$16
Amgen Inc.
$15
kaleo, Inc.
$13
Olympus America Inc.
$13
Boehringer Ingelheim Pharmaceuticals, Inc.
$11
AstraZeneca Pharmaceuticals LP
$11
Glenmark Therapeutics Inc.
$9
Top 3 companies account for 40.3% of all-time payments
Associated products mentioned in payments ›
ACCLARENT NAVWIRE SINUS NAVIGATION GUIDEWIRE · AREXVY · ARISTA AH · AUVI-Q · Auvi-Q · BREO · CINRYZE · CIPRODEX · CUVITRU · Coblation - Tonsil Wands · DERMATITIS - DISEASE · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dexilant · Dymista · EBGLYSS · ENTELLUS - XPRESS ENT DILATION SYSTEM · FASENRA · GAMMA · Grastek · Haegarda · Kcentra · Kloxxado · NUCALA · NUVENT · OPZELURA · Odactra · Otiprio · Otovel · SPIRIVA RESPIMAT · STEALTHSTATION S8 PLATFORM · TEZSPIRE · ThunderBeat · VIVAER STYLUS · XOLAIR · Xhance · Xolair
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an otolaryngology specialist in Bridgewater?
Compare otolaryngologists in the Bridgewater area by procedure volume, costs, and industry payment transparency.
Browse otolaryngologists nearby

Geographic Context

Otolaryngologists within 10 mi
121
Per 100K population
35.0
County median income
$135,960
Nearest hospital
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL - SOMERSET
3.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lazar is a clinical cardiology specialist, with above-average Medicare volume (top 22% in NJ), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lazar experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Lazar performed 571 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lazar receive payments from pharmaceutical companies?
Yes. Dr. Lazar received a total of $2,543 from 31 companies across 146 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lazar's costs compare to other otolaryngologists in Bridgewater?
Dr. Lazar's average Medicare payment per service is $95. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lazar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →